750P - Phase Ib study of PF-04136309 (an oral CCR2 inhibitor) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic adenocarcinoma
| Autor: | Noel, M., Lowery, M., Ryan, D., Wolpin, B., Bullock, A., Britten, C., Jin, B., Ganguly, B.J., Taylor, C.T., Yin, D., Wunderlich, D.A., Gamelin, E.C., Linehan, D.C. |
|---|---|
| Zdroj: | In Annals of Oncology September 2017 28 Supplement 5:v257-v257 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|